Charles W Hollen, DPH, MD in Oklahoma City: Medical Oncology and Cancer Care

Dr. Charles W Hollen holds both a doctorate in public health and an MD, bringing research-informed practice to medical oncology in Oklahoma City. He specializes in the treatment of solid tumors and works within the region's established oncology infrastructure, accepting most major insurance plans and maintaining appointment availability for both new and established patients.

What Charles W Hollen Actually Offers

Medical oncology focuses on chemotherapy, immunotherapy, and targeted drug treatments for cancer rather than surgical or radiation approaches. Dr. Hollen's training combines clinical oncology with public health credentials, a combination relatively uncommon in Oklahoma City's oncology landscape and one that shapes how he frames treatment plans within broader health outcomes. He sees adult patients with solid tumors across multiple cancer types, though specific clinical focus areas are best confirmed directly.

Services and What to Confirm

Medical oncologists in Oklahoma City typically offer initial consultations ($150 to $350 for new patients without insurance), followed by ongoing treatment visits where costs depend heavily on the specific chemotherapy regimen, insurance coverage, and whether treatment is inpatient or outpatient. Dr. Hollen's practice handles treatment planning, drug administration oversight, and symptom management. Because oncology pricing varies dramatically by drug choice and infusion setting, request an itemized estimate before starting treatment. Insurance copays for infusion services often range from $50 to $200 per session; deductibles apply separately.

How This Compares to Oklahoma City Oncology Options

Oklahoma City oncologists concentrate in a small number of centers. OU Health's oncology program operates multiple infusion centers and employs several medical oncologists with shorter average wait times for new-patient appointments (typically 1 to 3 weeks). Integris Health Cancer Institute similarly maintains a formal network with established referral pathways. Dr. Hollen's practice sits outside the largest health systems, which can mean more direct access to the physician but potentially less same-day scheduling flexibility and fewer on-site supportive services like nutritionists or social workers. Choose a larger system if coordinating care with surgery or radiation; choose a private oncologist like Dr. Hollen if continuity with one physician and a smaller clinic environment matter more.

Who This Suits and Who It Does Not

This practice suits patients who prefer seeing the same oncologist throughout treatment and who have insurance or can navigate out-of-network billing. It does not suit patients without transportation to a private clinic location or those who need immediate access to a full multidisciplinary team (surgical oncology, radiation, palliative care on-site). Patients with complex comorbidities who may benefit from same-building specialist collaboration often do better at a hospital-affiliated center.

What the First Visit Involves

New patients should bring insurance cards, photo ID, and any prior pathology reports or imaging if available. Dr. Hollen will review your cancer diagnosis, stage, and prior treatment (if any), perform a physical exam, and discuss treatment options. The visit typically lasts 45 to 90 minutes. Bring a list of all current medications and supplements. Most offices schedule a follow-up within one week to begin treatment if you and the doctor agree on a plan.

Hours, Location, and Logistics

Verify hours and exact address by calling ahead; oncology practices sometimes adjust schedules seasonally or for conferences. Parking details depend on the clinic location. If Dr. Hollen practices within a larger medical building, validated or free parking is often available; if in a standalone or shared office space, confirm before your first visit.

Dr. Hollen's DPH credential signals someone who thinks beyond a single patient's treatment to population health patterns, a less common angle in Oklahoma City oncology and one that can translate to more nuanced communication about prognosis and lifestyle factors during treatment.